Posts Tagged ‘recombinant tissue plasminogen activator’

June 25th, 2012

Selections from Richard Lehman’s Literature Review: June 25th

This week’s topics includes articles on industry regulation, the chronically comorbid, population risk for CV disease, and recombinant tissue plasminogen activator (rt-PA) for ischemic stroke.